Lung cancer biomarkers: Raising the clinical value of the classical and the new ones (Unknown)
Free access
- New search for: Holdenrieder, Stefan
- New search for: van Rossum, Huub H.
- New search for: van den Heuvel, Michel
- New search for: van Rossum, Huub
- New search for: Holdenrieder, Stefan
- New search for: van Rossum, Huub H.
- New search for: van den Heuvel, Michel
- New search for: van Rossum, Huub
In:
Tumor Biology
;
46
, s1
;
S1-S7
;
2024
- Article (Journal) / Electronic Resource
-
Title:Lung cancer biomarkers: Raising the clinical value of the classical and the new ones
-
Additional title:Lung cancer biomarkers
-
Contributors:Holdenrieder, Stefan ( author ) / van Rossum, Huub H. ( author ) / van den Heuvel, Michel ( author ) / van Rossum, Huub ( author )
-
Published in:Tumor Biology ; 46, s1 ; S1-S7
-
Publisher:
- New search for: IOS Press
-
Place of publication:Nieuwe Hemweg 6B, 1013 BG Amsterdam, The Netherlands
-
Publication date:2024-03-19
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:Unknown
-
Keywords:
-
Licence:
-
Source:
Table of contents – Volume 46, Issue s1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- S1
-
Lung cancer biomarkers: Raising the clinical value of the classical and the new onesHoldenrieder, Stefan / van Rossum, Huub H. / van den Heuvel, Michel / van Rossum, Huub et al. | 2024
- S9
-
Lung cancer tumor marker analysis: A clinical laboratory perspectivevan Rossum, Huub H. / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S15
-
Pre-analytical stability of the CEA, CYFRA 21.1, NSE, CA125 and HE4 tumor markersCanki, Esra / Schuurbiers, Milou MF / Linders, Theodora C. / Korse, Catharina M. / van den Heuvel, Michel M. / van Herwaarden, Antonius E. / van Rossum, Huub H. / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S27
-
Circulating lung cancer biomarkers: From translational research to clinical practiceQian, Xu / Meng, Qing-He / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S35
-
Factors influencing blood tumor marker concentrations in the absence of neoplasiaTrapé, Jaume / Fernández-Galán, Esther / Auge, Josep Maria / Carbonell-Prat, Marina / Filella, Xavier / Miró-Cañís, Sílvia / González-Fernández, Carolina / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S65
-
Screening approaches for lung cancer by blood-based biomarkers: Challenges and opportunitiesvan den Broek, Daniel / Groen, Harry J.M. / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S81
-
Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinationsTrulson, Inga / Klawonn, Frank / von Pawel, Joachim / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S99
-
Lung cancer tumor markers in serous effusions and other body fluidsTrapé, Jaume / Bérgamo, Silvia / González-Garcia, Laura / González-Fernández, Carolina / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S111
-
Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 updateTrulson, Inga / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S163
-
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scanMuley, Thomas / Schneider, Mark A. / Meister, Michael / Thomas, Michael / Heußel, Claus Peter / Kriegsmann, Mark / Holdenrieder, Stefan / Wehnl, Birgit / Rolny, Vinzent / Mang, Anika et al. | 2024
- S177
-
Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150Mang, Anika / Zou, Wei / Rolny, Vinzent / Reck, Martin / Cigoianu, Daniel / Schulze, Katja / Holdenrieder, Stefan / Socinski, Mark A. / Shames, David S. / Wehnl, Birgit et al. | 2024
- S191
-
Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudyGeiger, Kimberly / Joerger, Markus / Roessler, Max / Hettwer, Karina / Ritter, Christoph / Simon, Kirsten / Uhlig, Steffen / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S207
-
Clinical perspectives on serum tumor marker use in predicting prognosis and treatment response in advanced non-small cell lung cancerBuma, Alessandra I.G. / Schuurbiers, Milou M.F. / van Rossum, Huub H. / van den Heuvel, Michel M. / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S219
-
Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remissionMuley, Thomas / Herth, Felix J. / Heussel, Claus Peter / Kriegsmann, Mark / Thomas, Michael / Meister, Michael / Schneider, Marc A. / Wehnl, Birgit / Mang, Anika / Holdenrieder, Stefan et al. | 2024
- S233
-
Serum tumor markers for response prediction and monitoring of advanced lung cancer: A review focusing on immunotherapy and targeted therapiesvan den Heuvel, Michel / Holdenrieder, Stefan / Schuurbiers, Milou / Cigoianu, Daniel / Trulson, Inga / van Rossum, Huub / Lang, David et al. | 2024
- S269
-
Comparing modeling strategies combining changes in multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancervan Delft, Frederik A. / Schuurbiers, Milou M.F. / Muller, Mirte / Burgers, Sjaak A. / van Rossum, Huub H. / IJzerman, Maarten J. / van den Heuvel, Michel M. / Koffijberg, Hendrik / Holdenrieder, Stefan / van Rossum, Huub et al. | 2024
- S283
-
Circulating tumor DNA (ctDNA) as a biomarker for lung cancer: Early detection, monitoring and therapy predictionDuffy, Michael J. / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S297
-
A pocket companion to cell-free DNA (cfDNA) preanalyticsBronkhorst, Abel J. / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S309
-
Clinical significance of TP53 alterations in advanced NSCLC patients treated with EGFR, ALK and ROS1 tyrosine kinase inhibitors: An updateMoes-Sosnowska, Joanna / Szpechcinski, Adam / Chorostowska-Wynimko, Joanna / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S327
-
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancerMuller, Mirte / Best, Myron G. / van der Noort, Vincent / Hiltermann, T. Jeroen N. / Niemeijer, Anna-Larissa N. / Post, Edward / Sol, Nik / In ’t Veld, Sjors G.J.G. / Nogarede, Tineke / Visser, Lisanne et al. | 2024
- S341
-
Lack of clinical utility of serum macrophage migration inhibitory factor (MIF) for monitoring therapy response and estimating prognosis in advanced lung cancerRupp, Alexander / Bahlmann, Sophie / Trimpop, Nicolai / von Pawel, Joachim / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024
- S355
-
Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudyGeiger, Kimberly / Joerger, Markus / Roessler, Max / Hettwer, Karina / Ritter, Christoph / Simon, Kirsten / Uhlig, Steffen / Holdenrieder, Stefan / van Rossum, Huub / van den Heuvel, Michel et al. | 2024